Human Cell & Tissue Regulatory Framework
Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps) are regulated in the United States under the Public Health Service Act and the regulatory structure established in 21 CFR Part 1271.
These regulations define requirements related to donor eligibility determination, processing controls, traceability documentation, and current good tissue practices (cGTP) within establishments handling human tissue products.
Educational materials within this resource center provide structured explanations of regulatory terminology, compliance requirements, and documentation standards relevant to the evaluation of human tissue sourcing and manufacturing practices.
Regulatory Structure Under 21 CFR Part 1271
The regulatory framework governing HCT/Ps establishes requirements designed to protect public health through standardized controls governing the recovery, processing, storage, and distribution of human tissue products.
These regulatory provisions address areas including:
- Donor eligibility determination
- Establishment registration and listing
- Current Good Tissue Practices (cGTP)
- Traceability and recordkeeping
- Definitions governing minimal manipulation
- Interpretation of homologous use
Documentation-First Regulatory Evaluation
Responsible evaluation of biologic sourcing requires transparent documentation of donor screening procedures, manufacturing controls, traceability standards, and laboratory validation protocols prior to clinical procurement consideration.
Educational Purpose of This Resource Center
This regulatory education center is designed to support structured understanding of the legal and operational framework governing human tissue products used within regulated clinical environments.
Educational materials reference publicly available regulatory guidance, statutory frameworks, and documentation standards relevant to the responsible evaluation of biologic sourcing.
Regulatory References
- 21 CFR Part 1271 – Human Cells, Tissues, and Cellular and Tissue-Based Products
- 21 CFR 1271.10 – Criteria for regulation solely under Section 361
- 21 CFR 1271.50 – Donor Eligibility Determination
- 21 CFR 1271.150 – Current Good Tissue Practices
Educational reference only. Certain referenced materials may be regulated as Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps) under 21 CFR Part 1271. Registration under 21 CFR Part 1271 does not constitute FDA approval, clearance, or evaluation of safety or effectiveness. Not intended to diagnose, treat, cure, or prevent any disease. For use by licensed healthcare professionals.